NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Oct 19, 2016
Insider Transaction Report
Form 4
GOLDBERG MICHAEL M
Director
Transactions
- Other
Warrants (Right to Buy)
2016-10-17$2.07/sh+5,411,850$11,202,530→ 5,411,850 totalExercise: $0.01From: 2016-10-17Exp: 2035-08-20→ Common Stock (5,411,850 underlying)
Footnotes (1)
- [F1]Warrants acquired from Platinum Partners Value Arbitrage Fund pursuant to a Separation Agreement, dated March 28, 2014, and amended on June 11, 2015.